{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:08:13Z","timestamp":1791198493051,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00436-015-4652-3","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T01:12:57Z","timestamp":1438737177000},"page":"4195-4203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles"],"prefix":"10.1007","volume":"114","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Zhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Quan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"4652_CR1","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.biomaterials.2013.01.032","volume":"34","author":"AP Acharya","year":"2013","unstructured":"Acharya AP, Lewis JS, Keselowsky BG (2013) Combinatorial co-encapsulation of hydrophobic molecules in poly (lactide-co-glycolide) microparticles. Biomaterials 34:3422\u20133430","journal-title":"Biomaterials"},{"key":"4652_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrmicro1800","volume":"6","author":"JC Boothroyd","year":"2008","unstructured":"Boothroyd JC, Dubremetz JF (2008) Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat Rev Microbiol 6:79\u201388","journal-title":"Nat Rev Microbiol"},{"key":"4652_CR3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.exppara.2013.04.002","volume":"134","author":"SC Chuang","year":"2013","unstructured":"Chuang SC, Ko JC, Chen CP, Du JT, Yang CD (2013a) Encapsulation of chimeric protein rSAG1\/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice. Exp Parasitol 134:430\u2013437","journal-title":"Exp Parasitol"},{"key":"4652_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-3305-6-34","volume":"6","author":"SC Chuang","year":"2013","unstructured":"Chuang SC, Ko JC, Chen CP, Du JT, Yang CD (2013b) Induction of long-lasting protective immunity against Toxoplasma gondii in BALB\/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. Parasit Vectors 6:34","journal-title":"Parasit Vectors"},{"key":"4652_CR5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.159.4.1903","volume":"159","author":"EY Denkers","year":"1997","unstructured":"Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159:1903\u20131908","journal-title":"J Immunol"},{"key":"4652_CR6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","volume":"25","author":"M D\u00f6\u015fkaya","year":"2007","unstructured":"D\u00f6\u015fkaya M, Kalantari-Dehaghi M, Walsh CM, Hiszczy\u0144ska-Sawicka E, Davies DH, Felgner PL, Larsen LS, Lathrop RH, Hatfield GW, Schulz JR, G\u00fcr\u00fcz Y, Jurnak F (2007) GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine 25:1824\u201337","journal-title":"Vaccine"},{"key":"4652_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.vetpar.2009.05.018","volume":"164","author":"JP Dubey","year":"2009","unstructured":"Dubey JP (2009) Toxoplasmosis in pigs\u2014the last 20\u00a0years. Vet Parasitol 164:89\u2013103","journal-title":"Vet Parasitol"},{"key":"4652_CR8","first-page":"1","volume-title":"Toxoplasmosis of animals and humans","author":"JP Dubey","year":"2010","unstructured":"Dubey JP (2010) Toxoplasmosis of animals and humans, 2nd edn. CRC Press Inc, Boca Raton, Florida, pp 1\u2013313","edition":"2"},{"key":"4652_CR9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/bies.201100054","volume":"33","author":"SJ Fentress","year":"2011","unstructured":"Fentress SJ, Sibley LD (2011) The secreted kinase ROP18 defends Toxoplasma\u2019s border. Bioessays 33:693\u2013700","journal-title":"Bioessays"},{"key":"4652_CR10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/cmi.12022","volume":"14","author":"SJ Fentress","year":"2012","unstructured":"Fentress SJ, Steinfeldt T, Howard JC, Sibley LD (2012) The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii. Cell Microbiol 14:1921\u201333","journal-title":"Cell Microbiol"},{"key":"4652_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00436-014-4251-8","volume":"114","author":"B Gjerde","year":"2015","unstructured":"Gjerde B, Josefsen TD (2015) Molecular characterisation of Sarcocystis lutrae n. sp. and Toxoplasma gondii from the musculature of two Eurasian otters (Lutra lutra) in Norway. Parasitol Res 114:873\u2013886","journal-title":"Parasitol Res"},{"key":"4652_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1297-9716-44-48","volume":"44","author":"HC Guo","year":"2013","unstructured":"Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, Sun DH, Yin SH, Ma JW, Liu ZX, Guo JH, Luo JX, Yin H, Liu XT, Liu DX (2013) Foot-and mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 44:48","journal-title":"Vet Res"},{"key":"4652_CR13","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1017\/S0031182006001855","volume":"133","author":"EA Innes","year":"2006","unstructured":"Innes EA, Vermeulen AN (2006) Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133:S145\u2013168","journal-title":"Parasitology"},{"key":"4652_CR14","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2007.02.044","volume":"25","author":"EA Innes","year":"2007","unstructured":"Innes EA, Bartley PM, Maley SW, Wright SE, Buxton D (2007) Comparative host-parasite relationships in ovine toxoplasmosis and bovine neosporosis and strategies for vaccination. Vaccine 25:5495\u20135503","journal-title":"Vaccine"},{"key":"4652_CR15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1586\/erv.11.126","volume":"10","author":"S Jain","year":"2011","unstructured":"Jain S, O\u2019Hagan DT, Singh M (2011) The long-term potential of biodegradable poly (lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Rev Vaccines 10:1731\u20131742","journal-title":"Expert Rev Vaccines"},{"key":"4652_CR16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1023\/A:1018980020506","volume":"10","author":"H Jeffery","year":"1993","unstructured":"Jeffery H, Davis SS, O\u2019Hagan DT (1993) The preparation and characterization of poly (lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res 10:362\u2013368","journal-title":"Pharm Res"},{"key":"4652_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, F\u00f6rster-Waldl E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104:252\u201366","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4652_CR18","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2010.01.031","volume":"28","author":"E Jongert","year":"2010","unstructured":"Jongert E, Lemiere A, Van Ginderachter J, De Craeye S, Huygen K, D\u2019Souza S (2010) Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Vaccine 28:2556\u20132564","journal-title":"Vaccine"},{"key":"4652_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00436-006-0306-9","volume":"100","author":"C Lang","year":"2007","unstructured":"Lang C, Gross U, L\u00fcder CG (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100:191\u2013203","journal-title":"Parasitol Res"},{"key":"4652_CR20","doi-asserted-by":"crossref","first-page":"374696","DOI":"10.1155\/2009\/374696","volume":"2009","author":"J Matowicka-Karna","year":"2009","unstructured":"Matowicka-Karna J, Dymicka-Piekarska V, Kemona H (2009) Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009:374696","journal-title":"Clin Dev Immunol"},{"key":"4652_CR21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965\u20131976","journal-title":"Lancet"},{"key":"4652_CR22","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/IAI.00416-13","volume":"81","author":"W Niedelman","year":"2013","unstructured":"Niedelman W, Sprokholt JK, Clough B, Frickel EM, Saeij JP (2013) Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication. Infect Immun 81:4341\u20134349","journal-title":"Infect Immun"},{"key":"4652_CR23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2007.01.011","volume":"12","author":"E Petersen","year":"2007","unstructured":"Petersen E (2007) Toxoplasmosis. Semin Fetal Neonatal Med 12:214\u2013223","journal-title":"Semin Fetal Neonatal Med"},{"key":"4652_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","volume":"135","author":"D Qu","year":"2013","unstructured":"Qu D, Han J, Du A (2013) Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol 135:234\u2013239","journal-title":"Exp Parasitol"},{"key":"4652_CR25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264\u2013296","journal-title":"Clin Microbiol Rev"},{"key":"4652_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.12120","volume":"79","author":"N Salinas","year":"2014","unstructured":"Salinas N, Olguin JE, Castellanos C, Saavedra R (2014) T cell suppression in vitro during Toxoplasma gondii infection is the result of IL-2 competition between Tregs and T cells leading to death of proliferating T cells. Scand J Immunol 79:1\u201311","journal-title":"Scand J Immunol"},{"key":"4652_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-014-4176-2","volume":"114","author":"M Sharif","year":"2015","unstructured":"Sharif M, Sarvi S, Shokri A, Hosseini Teshnizi S, Rahimi MT, Mizani A, Ahmadpour E, Daryani A (2015) Toxoplasma gondii infection among sheep and goats in Iran: a systematic review and meta-analysis. Parasitol Res 114:1\u201316","journal-title":"Parasitol Res"},{"key":"4652_CR28","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2004.04.022","volume":"22","author":"AC Stanley","year":"2004","unstructured":"Stanley AC, Buxton D, Innes EA, Huntley JF (2004) Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine 22:3929\u20133941","journal-title":"Vaccine"},{"key":"4652_CR29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","volume":"240","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516\u2013518","journal-title":"Science"},{"key":"4652_CR30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00436-014-3801-4","volume":"113","author":"MM Tolba","year":"2014","unstructured":"Tolba MM, El-Taweel HA, Khalil SS, Hazzah WA, Heshmat MG (2014) Genotype analysis of T. gondii strains associated with human infection in Egypt. Parasitol Res 113:1563\u20131569","journal-title":"Parasitol Res"},{"key":"4652_CR31","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00436-013-3451-y","volume":"112","author":"F Wei","year":"2013","unstructured":"Wei F, Wang W, Liu Q (2013) Protein kinases of Toxoplasma gondii: functions and drug targets. Parasitol Res 112:2121\u20132129","journal-title":"Parasitol Res"},{"key":"4652_CR32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","volume":"39","author":"LM Weiss","year":"2009","unstructured":"Weiss LM, Dubey JP (2009) A history of clinical observations. Int J Parasitol 39:895\u2013901","journal-title":"Int J Parasitol"},{"key":"4652_CR33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/1471-2334-14-525","volume":"14","author":"Y Xu","year":"2014","unstructured":"Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ (2014) Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis 14:525","journal-title":"BMC Infect Dis"},{"key":"4652_CR34","doi-asserted-by":"crossref","unstructured":"Yang D, Liu J, Hao P, Wang J, Lei T, Shan D, Liu Q (2015) MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum. Parasitol Res (in press)","DOI":"10.1007\/s00436-015-4609-6"},{"key":"4652_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1743-422X-7-166","volume":"7","author":"S Yin","year":"2010","unstructured":"Yin S, Sun S, Yang S, Shang Y, Cai X, Liu X (2010) Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli. Virol J 7:166","journal-title":"Virol J"},{"key":"4652_CR36","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","volume":"29","author":"ZG Yuan","year":"2011","unstructured":"Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ (2011) Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 29:6614\u20136619","journal-title":"Vaccine"},{"key":"4652_CR37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","volume":"12","author":"NZ Zhang","year":"2013","unstructured":"Zhang NZ, Chen J, Wang M, Petersen E, Zhu XQ (2013) Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines 12:1287\u20131299","journal-title":"Expert Rev Vaccines"},{"key":"4652_CR38","doi-asserted-by":"crossref","unstructured":"Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, Zhu XQ (2015) Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines (in press)","DOI":"10.1586\/14760584.2015.1061938"},{"key":"4652_CR39","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","volume":"31","author":"B Zheng","year":"2013","unstructured":"Zheng B, Lu S, Tong Q, Kong Q, Lou D (2013) The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 31:4578\u20134584","journal-title":"Vaccine"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-015-4652-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4652-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T21:17:30Z","timestamp":1691875050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-015-4652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["4652"],"URL":"https:\/\/doi.org\/10.1007\/s00436-015-4652-3","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}